The Integrative Program from the Gateway for Cancer Research funds integrative oncology research that pairs conventional therapies with evidence-based integrative therapies to manage symptoms and side effects from treatment. Grants are typically 2-5 years in duration with award amounts from 200,000 to 1.5 million USD (no indirect costs). Applicants are required to first submit a letter of intent (LOI). Eligible applicants will be given 4-5 weeks to complete their full application.
The next LOI closing date is April 18, 2024.
April 18, 2024